Safety and efficacy of interrupting dual antiplatelet therapy one month following percutaneous coronary intervention: a meta-analysis of randomized controlled trials

Overview of attention for article published in BMC Cardiovascular Disorders, October 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

blogs: 1 blog

twitter: 19 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 14 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 1 blog post.

M-A | Safety and efficacy of interrupting dual antiplatelet therapy one month following percutaneous coronary intervention.

SPECIALTIES, 01 Nov 2022

Safety and efficacy of interrupting dual antiplatelet therapy one month following percutaneous coronary intervention: a meta-anal…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.